Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.66
-0.09 (-1.57%)
Nov 4, 2024, 4:00 PM EST - Market closed
Solid Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Cash & Equivalents | 95.85 | 74.02 | 155.38 | 119.14 | 154.74 | 76.04 | Upgrade
|
| Short-Term Investments | 94.41 | 49.63 | 58.34 | 88.64 | - | 7.48 | Upgrade
|
| Cash & Short-Term Investments | 190.27 | 123.64 | 213.72 | 207.78 | 154.74 | 83.52 | Upgrade
|
| Cash Growth | 18.77% | -42.15% | 2.86% | 34.27% | 85.27% | -31.80% | Upgrade
|
| Receivables | - | - | - | 0.11 | - | - | Upgrade
|
| Prepaid Expenses | 2.12 | 2.11 | 3 | 8.71 | 1.48 | 1.49 | Upgrade
|
| Other Current Assets | 5.22 | 3.98 | 2.91 | 6.02 | 2.67 | 1.29 | Upgrade
|
| Total Current Assets | 197.61 | 129.73 | 219.64 | 222.61 | 158.9 | 86.3 | Upgrade
|
| Property, Plant & Equipment | 30.95 | 33.16 | 38.61 | 7.6 | 11.73 | 16.63 | Upgrade
|
| Other Long-Term Assets | 2.43 | 2.04 | 2.01 | 2.16 | 0.54 | 0.54 | Upgrade
|
| Total Assets | 230.98 | 164.94 | 260.25 | 232.38 | 171.17 | 103.47 | Upgrade
|
| Accounts Payable | 2.52 | 2.03 | 3.24 | 4.46 | 3.27 | 7.12 | Upgrade
|
| Accrued Expenses | 9.92 | 10.14 | 16.69 | 9.53 | 8.64 | 9.18 | Upgrade
|
| Current Portion of Leases | 2.25 | 2.32 | 2.57 | 1.5 | 2.21 | 1.92 | Upgrade
|
| Current Unearned Revenue | - | - | - | 8.08 | 10.36 | - | Upgrade
|
| Other Current Liabilities | - | 0.02 | 0.01 | 0.04 | - | 0.05 | Upgrade
|
| Total Current Liabilities | 14.69 | 14.52 | 22.51 | 23.6 | 24.48 | 18.28 | Upgrade
|
| Long-Term Leases | 23.05 | 23.94 | 25.98 | 0.57 | 2.94 | 5.15 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 10.36 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.1 | - | 1.3 | - | Upgrade
|
| Total Liabilities | 37.74 | 38.46 | 48.59 | 24.17 | 39.08 | 23.42 | Upgrade
|
| Common Stock | 0.04 | 0.02 | 0.02 | 0.01 | 0.09 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 901.35 | 785.2 | 774.45 | 685.01 | 536.57 | 396.28 | Upgrade
|
| Retained Earnings | -708.13 | -658.75 | -562.74 | -476.76 | -404.57 | -316.28 | Upgrade
|
| Comprehensive Income & Other | -0.02 | 0.02 | -0.07 | -0.05 | - | 0 | Upgrade
|
| Total Common Equity | 193.25 | 126.48 | 211.67 | 208.21 | 132.09 | 80.05 | Upgrade
|
| Shareholders' Equity | 193.25 | 126.48 | 211.67 | 208.21 | 132.09 | 80.05 | Upgrade
|
| Total Liabilities & Equity | 230.98 | 164.94 | 260.25 | 232.38 | 171.17 | 103.47 | Upgrade
|
| Total Debt | 25.3 | 26.27 | 28.55 | 2.06 | 5.15 | 7.07 | Upgrade
|
| Net Cash (Debt) | 164.97 | 97.38 | 185.18 | 205.72 | 149.59 | 76.46 | Upgrade
|
| Net Cash Growth | 24.23% | -47.41% | -9.99% | 37.52% | 95.66% | -37.04% | Upgrade
|
| Net Cash Per Share | 5.53 | 4.90 | 21.75 | 28.90 | 43.20 | 28.46 | Upgrade
|
| Filing Date Shares Outstanding | 38.6 | 37.76 | 19.57 | 7.36 | 5.68 | 3.07 | Upgrade
|
| Total Common Shares Outstanding | 38.55 | 20.39 | 19.56 | 7.36 | 5.66 | 3.07 | Upgrade
|
| Working Capital | 182.92 | 115.22 | 197.13 | 199.01 | 134.42 | 68.03 | Upgrade
|
| Book Value Per Share | 5.01 | 6.20 | 10.82 | 28.30 | 23.34 | 26.11 | Upgrade
|
| Tangible Book Value | 193.25 | 126.48 | 211.67 | 208.21 | 132.09 | 80.05 | Upgrade
|
| Tangible Book Value Per Share | 5.01 | 6.20 | 10.82 | 28.30 | 23.34 | 26.11 | Upgrade
|
| Machinery | - | 17.92 | 17.96 | 11.37 | 10.27 | 10.06 | Upgrade
|
| Construction In Progress | - | 0.41 | 1.72 | 1.49 | 1.33 | 1.32 | Upgrade
|
| Leasehold Improvements | - | 0.48 | 0.38 | 4.71 | 4.71 | 4.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.